N
ORMP icon

Nuveen’s Oramed Pharmaceuticals ORMP Stock Holding History

Nuveen’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-154,729
Closed -$1.46M – 3424
2022
Q1 		$1.46M Sell
154,729
-3,911
-2% -$40.1K ﹤0.01% 2658
2021
Q4 		$2.27M Buy
158,640
+66,859
+73% +$1.4M ﹤0.01% 2513
2021
Q3 		$1.88M Sell
91,781
-160
-0.2% -$2.73K ﹤0.01% 2699
2021
Q2 		$1.23M Buy
+91,941
New +$1.05M ﹤0.01% 2929

Other funds holding ORMP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return